Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 20, 2005Shock

HMGB-1 as a Therapeutic Target for Infectious and Inflammatory Disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLin L. MantellNorthwell HealthWPWilliam R. ParrishNorthwell HealthLULuis UlloaRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mantell et al. (2005) studied this question.

synapsesocial.com/papers/6a7f90074ae0097cbfb112d5https://doi.org/10.1097/01.shk.0000188710.04777.9e
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TUMOR NECROSIS FACTOR IN SEPSIS: MEDIATOR OF MULTIPLE ORGAN FAILURE OR ESSENTIAL PART OF HOST DEFENSE?1995 · 231 citations
  2. 2Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis2005 · 121 citations
  3. 3Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia1992 · 326 citations
  4. 4High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine2003 · 484 citations